临床试验协议的潜在注册:什么时候与健康相关的干预研究不是"临床试验"?
Daniel Bressington1, Wachira Suriyawong1, Noppamas Pipatpiboon1
1Faculty of Nursing, Chiang Mai University, Chiang Mai 50200, Thailand.
Nursing reports (Pavia, Italy)
|January 27, 2026
概括
临床试验是研究研究,评估人类参与者的健康干预措施,以确定它们对健康结果的影响. 这些研究对于推进医学知识和改善患者护理至关重要.
科学领域:
- 临床研究方法论临床研究方法论
- 健康研究成果研究结果
背景情况:
- 世界卫生组织 (WHO) 为临床试验提供了一个标准化的定义.
- 对于研究人员和监管机构来说,了解定义至关重要.
研究的目的:
- 根据世界卫生组织,澄清临床试验的定义.
- 建立对临床试验研究的基本理解.
主要方法:
- 分析世界卫生组织对临床试验的定义.
- 审查人类参与者对与健康有关的干预措施的潜在分配.
主要成果:
- 临床试验涉及对人类参与者的预期分配.
- 干预措施与健康有关,旨在评估对健康结果的影响.
结论:
- 世卫组织的定义为确定和进行临床试验提供了一个明确的框架.
- 准确理解这一定义对于伦理和有效的临床研究至关重要.
更多相关视频
06:28E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
相关概念视频
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...